Biochemist Jennifer Doudna, a faculty scientist at the Department of Energy’s Lawrence Berkeley National Laboratory, founder of the Innovative Genomics Institute, and a professor at UC Berkeley, has ...

On Monday, scientists at UC Berkeley's Doudna Lab published research on a new system for targeting RNA sequences using clustered regularly interspaced short palindromic repeats, or CRISPR, an adaptive ...

The technology known as CRISPR is considered one of modern biology’s biggest breakthroughs. It allows scientists to edit genes, similarly to how you cut and paste text in a word processor. More than a ...

It took five years to sequence the first human genome. Today, it takes less than 24 hours. Rapid genome sequencing is one of the many advances indebted to CRISPR-Cas9, the powerful gene editing ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 genome editing, has been awarded a National Medal of Technology and Innovation, ...

Since discovering the technique, Doudna and Charpentier went their separate ways and began building on their finding — and just about every other genome lab in the world followed suit. There’s a rush ...

Nobel Prize–winning biochemist Dr. Jennifer Doudna is cracking the code of nature to address big issues, using the tiniest parts of us. On Tuesday, UCSB Arts & Lectures and the Cancer Foundation of ...

Last month, Genetic Engineering & Biotechnology News hosted “The State of Biotech” virtual summit, packed full of amazing conversations with scientists, physicians, executives, and analysts driving ...

Doudna has distanced herself from the battle, aside from providing lab notebooks and other documentation to support Berkeley’s and University of Vienna’s case. But she appreciates that such legal ...

Owen T. Tuck, a graduate student in Jennifer Doudna’s lab at the University of California. Owen T. Tuck, a graduate student in Jennifer Doudna’s lab at the University of California, Berkeley, thinks ...

LOS ANGELES — That the honor of opening the Presidential Symposium of the American Society of Gene and Cell Therapy (ASGCT) conference should fall to 2020 Nobel laureate Jennifer Doudna, PhD, the ...